Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Paclitaxel-Induced Peripheral Neuropathy
NCT03492047Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Apr 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of acetylcysteine in chemotherapy-induced peripheral neuropathy (CIPN) (3 arms), sponsored by Ain Shams University. Primary endpoint: Incidence of chemotherapy induced-peripheral neuropathy at 12 weeks. Started Apr 2018; status: completed.
02
Drugs
acetylcysteine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT03492047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03492047.